Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ensysce Biosciences Inc
ENSC
Alternate Symbol(s):
ENSCW
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology...
, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENSC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on May 09, 2023 8:01am
New Press Release - Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection
~ Represents Major Milestone Towards Launch of PF614-MPAR ~~ PF614-MPAR on Track to be the First Drug to Protect Against Overdose ~SAN DIEGO, CA / ACCESSWIRE / May 9, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), clinical-stage biotech company applying transformative chemistry to improve...
read article.
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 2:13pm
ENSC...... Is that a lil gap down ?
Vols have dried up....share price is getting whack.... Mr. M is licking his chops and laughing all the way to the bank. Now he's sayin..... Anymore weak hands?
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 1:58pm
ENSC.... 3rd 2 x's double bottom since 1 hr post open
And now for the next shoe to drop to sub $4 Wait for it ....Just keepin it real ; ) JMHO
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 12:32pm
ENSC..... It looks like The Maggots are playing a different
trading style these days. Just to screw everyone around and to not let John. Q Public know what they are doing. This deal is going to tank..... JMHO currently at $4.67
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 11:56am
ENSC..... By the way..... all the Frontloaders will be
re-loading sub $4.72 Cheers !
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 11:51am
ENSC...... support at $4.78
Forgot to mention ; )
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 11:50am
ENSC...... I guess that's all you get ; )
A big flash in the pan breakout to the H.O.D.....then it goes stone cold with volumes decreasing on the 5 min chart Oh well.... I guess all the Frontloaders post RS have had their fun On to
...more
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 11:35am
ENSC ..... I'd say a break over $6.10 will send this
into the stratossphere Watching for a volume spike and price action P.O's take a lot of maniping to pre-sell Me no position
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 11:29am
ENSC......... Nice !
Straight to N.H.O.D .... $5.90 !!!! Thank you very much ; )
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 11:16am
ENSC.....Flagging on the 5 min chart
Whats it going to be Maggot ? $5.28
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 19, 2023 10:29am
ENSC..... Prelude to a P.O ????????
Somethings never change.....The NR this a.m was pure "Fluff" RS last March 31/23 ..... And there was no announcement (nothing on SW that I pay for) No transparency on this deal Is this
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 04, 2023 8:05am
New Press Release - Ensysce Biosciences Announces Successful Completion of Clinical Portion of Oral Human Abuse Potential Trial
Data Expected in March 2023SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC, OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today...
read article.
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 19, 2022 8:26am
ENSC.... On watch NR this a.m
Cheers !
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 19, 2022 8:13am
New Press Release - Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection
~ PF614-MPAR will be the Industry's First Overdose Protection Pain Product ~SAN DIEGO, CA / ACCESSWIRE / December 19, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve...
read article.
(120)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 07, 2022 10:49am
ENSC...... P.O announced
Mr. M says thanks for your support ; ) He loves selling u high priced paper Don't quit your day job
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Maiden Resource Estimate of 54 Moz at 284 gpt Silver, Highlights High-Grade Potential at Columba
Freegold Achieves over 90% Gold Recovery Using BIOX® and greater than 92% Gold Recovery using POX
Gold rush 2025: Why Desert Gold Ventures Inc. is now on the brink of a historic revaluation!
Eminent Continues to Hit Gold Mineralization at its Hot Springs Range Project in Nevada